JPWO2021182573A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021182573A5 JPWO2021182573A5 JP2021532006A JP2021532006A JPWO2021182573A5 JP WO2021182573 A5 JPWO2021182573 A5 JP WO2021182573A5 JP 2021532006 A JP2021532006 A JP 2021532006A JP 2021532006 A JP2021532006 A JP 2021532006A JP WO2021182573 A5 JPWO2021182573 A5 JP WO2021182573A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025053695A JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020043021 | 2020-03-12 | ||
| JP2020043021 | 2020-03-12 | ||
| PCT/JP2021/009798 WO2021182573A1 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025053695A Division JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021182573A1 JPWO2021182573A1 (https=) | 2021-09-16 |
| JPWO2021182573A5 true JPWO2021182573A5 (https=) | 2024-02-28 |
| JP7797875B2 JP7797875B2 (ja) | 2026-01-14 |
Family
ID=77671643
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532006A Active JP7797875B2 (ja) | 2020-03-12 | 2021-03-11 | 癌の治療及び／又は予防のための医薬品 |
| JP2025053695A Pending JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025053695A Pending JP2025092589A (ja) | 2020-03-12 | 2025-03-27 | 癌の治療及び／又は予防のための医薬品 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230129035A1 (https=) |
| EP (1) | EP4119156A4 (https=) |
| JP (2) | JP7797875B2 (https=) |
| KR (1) | KR20220152318A (https=) |
| BR (1) | BR112022018157A2 (https=) |
| CA (1) | CA3175137A1 (https=) |
| WO (1) | WO2021182573A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101638490B1 (ko) * | 2008-08-05 | 2016-07-11 | 도레이 카부시키가이샤 | 암의 치료 및 예방용 의약 조성물 |
| WO2023008459A1 (ja) * | 2021-07-27 | 2023-02-02 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| AU2022316644A1 (en) * | 2021-07-27 | 2024-02-29 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| CN117677398A (zh) * | 2021-07-27 | 2024-03-08 | 东丽株式会社 | 用于癌的治疗和/或预防的药品 |
| EP4578457A1 (en) * | 2022-08-24 | 2025-07-02 | Toray Industries, Inc. | Pharmaceutical for treating and/or preventing cancer |
| KR20250052364A (ko) * | 2022-08-24 | 2025-04-18 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
| AU2023329564A1 (en) * | 2022-08-24 | 2025-02-27 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| JPWO2024190815A1 (https=) * | 2023-03-14 | 2024-09-19 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| CA2194907A1 (en) | 1994-07-13 | 1996-02-01 | Kouji Matsushima | Reshaped human antibody against human interleukin-8 |
| US6677436B1 (en) | 1998-04-03 | 2004-01-13 | Chugai Seiyaku Kabushiki Kaisha | Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody |
| ES2434961T5 (es) | 1998-04-20 | 2018-01-18 | Roche Glycart Ag | Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| EP1176195B1 (en) | 1999-04-09 | 2013-05-22 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
| FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
| JP2006524039A (ja) | 2003-01-09 | 2006-10-26 | マクロジェニクス，インコーポレーテッド | 変異型Ｆｃ領域を含む抗体の同定および作製ならびにその利用法 |
| US8388955B2 (en) | 2003-03-03 | 2013-03-05 | Xencor, Inc. | Fc variants |
| DE10359795A1 (de) | 2003-12-19 | 2005-07-21 | Bayer Technology Services Gmbh | Strangverdampfervorrichtung |
| KR101638490B1 (ko) | 2008-08-05 | 2016-07-11 | 도레이 카부시키가이샤 | 암의 치료 및 예방용 의약 조성물 |
| AU2010270979B2 (en) | 2009-06-22 | 2015-04-23 | Medimmune, Llc | Engineered Fc regions for site-specific conjugation |
| SG178925A1 (en) | 2009-09-22 | 2012-04-27 | Volker Sandig | Process for producing molecules containing specialized glycan structures |
| HUE025678T2 (en) | 2010-02-04 | 2016-04-28 | Toray Industries | A pharmaceutical composition for the treatment and / or prevention of cancer |
| MX342291B (es) | 2010-02-04 | 2016-09-23 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. |
| KR101842893B1 (ko) * | 2010-02-04 | 2018-03-28 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| MX340015B (es) | 2010-02-04 | 2016-06-22 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. |
| RU2598258C2 (ru) | 2010-02-04 | 2016-09-20 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
| BR112012018943A8 (pt) | 2010-02-04 | 2017-12-19 | Toray Industries | medicamento e método para o tratamento e/ou prevenção de um câncer |
| BR112012024489A2 (pt) | 2010-03-29 | 2016-05-31 | Zymeworks Inc | anticorpos com função efetora suprimida ou aumentada |
| RU2595400C2 (ru) | 2011-08-04 | 2016-08-27 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли |
| PT2740794T (pt) | 2011-08-04 | 2018-06-14 | Toray Industries | Composição farmacêutica para o tratamento e/ou profilaxia de cancro |
| US9181348B2 (en) | 2011-08-04 | 2015-11-10 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| PT2740793T (pt) | 2011-08-04 | 2018-02-23 | Toray Industries | Composição de fármacos para o tratamento e/ou a prevenção de cancro |
| KR102041832B1 (ko) | 2011-08-04 | 2019-11-08 | 도레이 카부시키가이샤 | 췌장암의 치료 및/또는 예방용 의약 조성물 |
| JP6070191B2 (ja) | 2011-08-04 | 2017-02-01 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| PT2818483T (pt) | 2012-02-21 | 2017-10-09 | Toray Industries | Composição medicinal para tratamento e/ou prevenção de cancro |
| BR112014021103A2 (pt) | 2012-02-21 | 2019-10-15 | Toray Industries, Inc | Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo |
| US9260513B2 (en) | 2012-02-21 | 2016-02-16 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| HUE044611T2 (hu) | 2012-02-21 | 2019-11-28 | Toray Industries | Gyógyászati készítmény rák kezelésére |
| PT2832366T (pt) | 2012-03-30 | 2018-01-25 | Toray Industries | Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar |
| KR102155531B1 (ko) | 2012-03-30 | 2020-09-15 | 도레이 카부시키가이샤 | 간암의 치료 및/또는 예방용 의약 조성물 |
| CN112587671A (zh) | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| ES2704909T3 (es) | 2013-08-09 | 2019-03-20 | Toray Industries | Composición farmacéutica para el tratamiento y/o la prevención del cáncer |
| JP2020524694A (ja) | 2017-06-22 | 2020-08-20 | ノバルティス アーゲー | がんの処置における使用のためのＩＬ−１β結合性抗体 |
| JP7342701B2 (ja) * | 2018-03-30 | 2023-09-12 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| JP7103097B2 (ja) | 2018-09-13 | 2022-07-20 | トヨタ自動車株式会社 | 燃料電池車両 |
-
2021
- 2021-03-11 KR KR1020227035364A patent/KR20220152318A/ko active Pending
- 2021-03-11 BR BR112022018157A patent/BR112022018157A2/pt unknown
- 2021-03-11 EP EP21767020.7A patent/EP4119156A4/en active Pending
- 2021-03-11 JP JP2021532006A patent/JP7797875B2/ja active Active
- 2021-03-11 CA CA3175137A patent/CA3175137A1/en active Pending
- 2021-03-11 WO PCT/JP2021/009798 patent/WO2021182573A1/ja not_active Ceased
- 2021-03-11 US US17/910,538 patent/US20230129035A1/en active Pending
-
2025
- 2025-03-27 JP JP2025053695A patent/JP2025092589A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021182573A5 (https=) | ||
| AU2019242520B2 (en) | Pharmaceutical composition for treatment and/or prevention of cancer | |
| JP7797875B2 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| CN119789868A (zh) | 用于癌的治疗和/或预防的药品 | |
| US20250228937A1 (en) | Medicament for treatment and/or prevention of cancer | |
| JPWO2021182574A5 (https=) | ||
| JP7715041B2 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| JPWO2021182571A5 (https=) | ||
| JP7793986B2 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| JPWO2021182570A5 (https=) | ||
| US20230159635A1 (en) | Medicament for treatment and/or prevention of cancer | |
| JPWO2021182572A5 (https=) | ||
| JP7793985B2 (ja) | 癌の治療及び／又は予防のための医薬品 | |
| US20240325529A1 (en) | Medicament for treatment and/or prevention of cancer | |
| EP4578458A1 (en) | Medicament for treatment and/or prevention of cancer | |
| EP4578459A1 (en) | Pharmaceutical product for treatment and/or prevention of cancer | |
| EP4640235A1 (en) | Medicament for treatment and/or prevention of cancer | |
| CN119768182A (zh) | 用于癌的治疗和/或预防的药品 |